1-4 of 4
Henrik Frederiksen
Close
Sort by
Journal Articles

A leap in recognizing drug-induced immune hemolytic anemia

Clinical Trials & Observations
Dennis Lund Hansen, Henrik Frederiksen
Journal: Blood Advances
Blood Adv (2024) 8 (3): 815–816.
https://doi.org/10.1182/bloodadvances.2023011842
Published: 2024
Journal Articles

Risk of diabetes and the impact on preexisting diabetes in patients with lymphoma treated with steroid-containing immunochemotherapy

Joachim Baech, Marianne Tang Severinsen, Andreas K. Øvlisen, Henrik Frederiksen, Peter Vestergaard, Christian Torp-Pedersen, Judit Jørgensen, Michael Roost Clausen, Christian B. Poulsen, Peter Brown, Anne Ortved Gang, Robert Schou Pedersen, Karin Ekström Smedby, Sandra Eloranta, Lasse Hjort Jakobsen, Tarec Christoffer El-Galaly
Journal: Blood Advances
Blood Adv (2022) 6 (15): 4427–4435.
https://doi.org/10.1182/bloodadvances.2021006859
Published: 2022
Includes: Supplemental data
Journal Articles

The CLL comorbidity index in a population-based cohort: a tool for clinical care and research

Emelie C. Rotbain, Max J. Gordon, Noomi Vainer, Henrik Frederiksen, Henrik Hjalgrim, Alexey V. Danilov, Carsten U. Niemann
Journal: Blood Advances
Blood Adv (2022) 6 (8): 2701–2706.
https://doi.org/10.1182/bloodadvances.2021005716
Published: 2022
Includes: Supplemental data
Journal Articles

Evans syndrome in adults: an observational multicenter study

Clinical Trials & Observations
Bruno Fattizzo, Marc Michel, Juri Alessandro Giannotta, Dennis Lund Hansen, Maria Arguello, Emanuele Sutto, Nicola Bianchetti, Andrea Patriarca, Silvia Cantoni, María Eva Mingot-Castellano, Vickie McDonald, Marco Capecchi, Anna Zaninoni, Dario Consonni, Josephine Mathilde Vos, Nicola Vianelli, Frederick Chen, Andreas Glenthøj, Henrik Frederiksen, Tomás José González-López, Wilma Barcellini
Journal: Blood Advances
Blood Adv (2021) 5 (24): 5468–5478.
https://doi.org/10.1182/bloodadvances.2021005610
Published: 2021
Includes: Supplemental data